A vital aspect of device and implant regulation is continual surveillance o
f performance after approval. Most permanent implants seldom reveal their s
trengths and weaknesses until they have been in clinical use for a number o
f years. It is vital that clinicians report problems to the manufacturers a
nd regulatory authorities to enable emerging hazards to be promptly identif
ied.